Company

Tcelltech GmbH

Biotechnology Research De 4 employees

Employees: 4
Contacts: 1
Emails: 1

www.tcelltech.eu LinkedIn

Tcelltech GmbH Overview

Headquarters: De
Website: www.tcelltech.eu
Industry: Biotechnology Research
Employees: 4
Founded: 2022
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Cell Therapy Cancer Vaccines Non-viral Gene Delivery T cell Receptor Identification T cell Therapy nanoSMAR

About Tcelltech GmbH

Tcelltech GmbH, a spin-out of the German Cancer Research Center (DKFZ), envisages developping a universal personalised adoptive cell therapy against all cancers (UNIPACT). UNIPACT is based on two platform technologies: (I) High performance gene expressing DNA vector (nanoSMAR) (II) AI bioinformatics platform for reactive T cell receptor identification (selecTCR). Managing Directors: Prof. Dr. Michael Platten, Dr. Edward Green, Dr. Richard Harbottle, Dr. Mathias Turwitt HRB 745600 AG Mannheim

Tcelltech GmbH Contact Details

People in AeroLeads: 4
With contact data: 1
Email contacts: 1; 25.0% coverage

Tcelltech GmbH Org Chart

Sample employees and titles

Name	Title	Location	Contact
Mathias Turwitt	Finance at Tcelltech	Hamburg, Germany	View
Michael Platten	Chairman, Department of Neurology		View
Edward Green, Phd		Heidelberg, Baden-württemberg, Germany	Email
Jochen Dieselhorst	Senior Legal Advisor - Pharma Biotech	Hamburg, Germany	View